LOS ANGELES—Medical device company Neoteryx has a reputation for providing extraordinary customer service and support to its scientific and healthcare customers in research, clinical trials, laboratory services, and payer/provider networks.
Neoteryx has rapidly scaled up production and shipping of its Mitra products to support SARS-CoV-2 studies and others being carried out by customers such as UC San Diego, the University of Rochester, the National Institutes of Health (NIH), and LGC Group, to name a few. Several customers requested changes in packaging and labeling that would help them better manage logistical and budgetary considerations when storing and deploying Mitra Collection Kits. The Neoteryx team responded by forming a committee to redesign and reconfigure several product features based on customer feedback.
Neoteryx is pleased to announce it has made several updates and improvements to its Mitra Collection Kit packaging. Going forward, all kit components will be packaged in a box with smaller dimensions (7 1/4” (L) x 6 1/4” (W) x 11 1/8” (D) vs. 11 5/8” x 6 5/8" x 1 1/16"), and updated labeling.
Neoteryx is grateful for the collaborative spirit of its customers, and to be able to manufacture and fulfill increasing quantities of our Mitra microsampling devices and Mitra Collection Kits to an expanding network of microsampling innovators and adopters. The company is busy working on some additional updates that will be announced in the coming months.
For more information about Mitra microsampling, or to get a sample of Neoteryx’s new and improved Mitra Collection Kit, please contact your Microsampling Specialist or email the Neoteryx microsampling team at: info@neoteryx.com